A two-drug combination pill dramatically reduced deaths among blacks with heart failure, a landmark finding that is expected to lead to government approval of the first medication marketed for a specific race.
Black cardiologists hailed this form of racial profiling after years in which minorities got short shrift in medical studies. Others complained that the drug also might help whites and should have been tested in them, but wasn't for business reasons.
"At times you can't win," said Dr. Augustus Grant, past president of the Association of Black Cardiologists, which supported the study. "Here we have a wonderful trial that shows a clear result and the issue is raised, `Why was this trial only done in African Americans?'"
The nationwide study is the largest ever done solely on blacks with heart failure. The findings were reported Monday at an American Heart Association meeting in New Orleans and will be published tomorrow in the New England Journal of Medicine. The drug's maker plans to seek Food and Drug Administration approval by the end of the year.
Heart failure affects 5 million Americans, but blacks are 2 1/2 times more likely to develop it. It happens when the heart is too weak to pump effectively, causing fluid to back up in the lungs and leaving people weak and short of breath. Half die within five years of diagnosis.
Earlier research suggested that standard heart failure drugs called ACE inhibitors do not work as well in blacks, and that blacks may have lower amounts of nitric oxide, which plays many roles in heart health, in their blood.
Two chemicals -- isosorbide dinitrate and hydralazine -- boost this substance, but administering the right dose is complicated when they are prescribed separately. A Massachusetts biotechnology company, NitroMed, developed a combination pill, BiDil, that gets around this problem, but the FDA refused to license it as a new drug because earlier studies involving mostly white patients who got the chemicals separately showed no benefit.
But there were tantalizing signs that BiDil helped the few blacks in the studies, and NitroMed won a patent to use it just in that minority group.
The company then launched a study of 1,050 blacks. Half of them got standard heart failure drugs and a placebo; the other half got those drugs plus BiDil. The study was stopped ahead of schedule last year when doctors saw BiDil clearly was better.
After roughly two years' use, only 6.2 percent of the patients who took BiDil had died versus 10.2 percent who got only standard heart failure drugs. That translates to a 43 percent reduction in deaths, said Dr. Anne Taylor of the University of Minnesota, one of the study's leaders.
Only 16.4 percent on BiDil required hospitalization for heart failure, versus 24.4 percent of the rest.
BiDil had substantial side effects -- 47.5 percent on it had headaches, compared with 19.2 of the others. Dizziness occurred in 29.3 percent on the drug and 12.3 percent on fake pills.
But the favorable overall result "virtually ensures FDA approval," because the agency previously told the company that a successful study in blacks would merit it, Dr. M. Gregg Bloche, a Georgetown University lawyer and Johns Hopkins University physician, said in a commentary in the medical journal.
That is "cause for celebration" for blacks, but the company now will have no financial incentive to do a larger trial in whites because its "black-only" patent allows it to sell it that way and keep generic versions from coming the market until 2020, he said.
Others worried that the drug might not be the best choice for every black but that they will automatically be prescribed "the black pill" solely on the basis of skin color.
Being black is not a black-and-white distinction, said Dr. Timothy Gardner of the University of Pennsylvania in Philadelphia, who had no role in the study. "Physiologically, it's a sort of continuous variable," including people of mixed races, he said.
Le Tuan Binh keeps his Moroccan soldier father’s tombstone at his village home north of Hanoi, a treasured reminder of a man whose community in Vietnam has been largely forgotten. Mzid Ben Ali, or “Mohammed” as Binh calls him, was one of tens of thousands of North Africans who served in the French army as it battled to maintain its colonial rule of Indochina. He fought for France against the Viet Minh independence movement in the 1950s, before leaving the military — as either a defector or a captive — and making a life for himself in Vietnam. “It’s very emotional for me,”
The Chinese Communist Party’s (CCP) Central Committee is to gather in July for a key meeting known as a plenum, the third since the body of elite decisionmakers was elected in 2022, focusing on reforms amid “challenges” at home and complexities broad. Plenums are important events on China’s political calendar that require the attendance of all of the Central Committee, comprising 205 members and 171 alternate members with Chinese President Xi Jinping (習近平) at the helm. The Central Committee typically holds seven plenums between party congresses, which are held once every five years. The current central committee members were elected at the
Indian Prime Minister Narendra Modi reaffirmed his pledge to replace India’s religion-based marriage and inheritance laws with a uniform civil code if he returns to office for a third term, a move that some minority groups have opposed. In an interview with the Times of India listing his agenda, Modi said his government would push for making the code a reality. “It is clear that separate laws for communities are detrimental to the health of society,” he said in the interview published yesterday. “We cannot be a nation where one community is progressing with the support of the Constitution while the other
CODIFYING DISCRIMINATION: Transgender people would be sentenced to three years in prison, while same-sex relations could land a person in jail for more than a decade Iraq’s parliament on Saturday passed a bill criminalizing same-sex relations, which would receive a sentence of up to 15 years in prison, in a move rights groups condemned as an “attack on human rights.” Transgender people would be sentenced to three years’ jail under the amendments to a 1988 anti-prostitution law, which were adopted during a session attended by 170 of 329 lawmakers. A previous draft had proposed capital punishment for same-sex relations, in what campaigners had called a “dangerous” escalation. The new amendments enable courts to sentence people engaging in same-sex relations to 10 to 15 years in prison, according to the